Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jeffrey Rogers

Obstetrics & Gynecology St George, UT Medical Doctor

NPI 1588664312 CMS profile 298751

295 S 1470 E Ste 200, St George, UT 84790

Open in the dashboard

General payments

$35,870

192 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jeffrey Rogers of St George, UT is reported in the CMS Open Payments database as having received $35,870 across 192 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $198 8
2024 General $1,712 10
2023 General $19,775 68
2022 General $12,454 49
2021 General $516 27
2020 General $408 19
2019 General $807 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffrey Rogers
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Jeffrey Rogers were reported at $198. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Jeffrey Rogers Obstetrics & Gynecology median Middle half National median
2019 $807 $172 $62–$391 $163
2020 $408 $94 $36–$222 $114
2021 $516 $136 $42–$369 $132
2022 $12,454 $160 $50–$433 $149
2023 $19,775 $169 $56–$423 $160
2024 $1,712 $152 $50–$371 $164
2025 $198 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organon LLC $29,337 68 payments
  2. Medical Device Business Services, Inc. $2,120 8 payments
  3. Boston Scientific Corporation $2,094 36 payments
  4. Coloplast Corp $775 8 payments
  5. Ethicon US, LLC $488 16 payments
  6. AbbVie, Inc. $391 21 payments
  7. Hologic, LLC $155 8 payments
  8. Evofem Biosciences, Inc. $86 5 payments
  9. Mayne Pharma Inc. $71 4 payments
  10. Daiichi Sankyo Inc. $53 3 payments
  11. Other $301 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $28,755 44 payments
  2. Food and Beverage $3,687 140 payments
  3. Travel and Lodging $3,429 8 payments
Products named General payments · program years 2019–2025
  1. NEXPLANON $29,327 67 payments
  2. Enseal $2,068 7 payments
  3. Solyx SIS System $1,338 11 payments
  4. ALTIS $749 7 payments
  5. Enseal X1 $425 8 payments
  6. VISTASEAL $262 11 payments
  7. ORILISSA $253 14 payments
  8. ORIAHNN $252 14 payments
  9. Obtryx System - Curved $216 8 payments
  10. DERMABOND PRINEO $194 3 payments
  11. Other $1,595 69 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

146

Median for Obstetrics & Gynecology: 65

Drug cost

$2,662

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

26%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 43 $1,951
Solifenacin Succinate Generic 19 $393
Celecoxib Generic 21 $102
Oxybutynin Chloride Er Oxybutynin Chloride Brand 12 $72
Ibuprofen Generic 25 $69
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 15 $45
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $30

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$36,585

Medicare's payments for the services billed

Medicare patients

65

Average age 72

Services billed

231

65 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 52%
Arthritis 42%
Depression 23%
Osteoporosis 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
MYFEMBREE
  • Sumitomo Pharma America, Inc. $24
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

192 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record